Publication Date:
2018-12-06
Description:
A retrospective comparison of allogenic and autologous chimeric antigen receptor T cell therapy targeting CD19 in patients with relapsed/refractory acute lymphoblastic leukemia A retrospective comparison of allogenic and autologous chimeric antigen receptor T cell therapy targeting CD19 in patients with relapsed/refractory acute lymphoblastic leukemia, Published online: 05 December 2018; doi:10.1038/s41409-018-0403-2 A retrospective comparison of allogenic and autologous chimeric antigen receptor T cell therapy targeting CD19 in patients with relapsed/refractory acute lymphoblastic leukemia
Print ISSN:
0268-3369
Electronic ISSN:
1476-5365
Topics:
Medicine